1. Home
  2. WIMI vs ARMP Comparison

WIMI vs ARMP Comparison

Compare WIMI & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WIMI
  • ARMP
  • Stock Information
  • Founded
  • WIMI 2015
  • ARMP N/A
  • Country
  • WIMI China
  • ARMP United States
  • Employees
  • WIMI N/A
  • ARMP N/A
  • Industry
  • WIMI Computer Software: Prepackaged Software
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WIMI Technology
  • ARMP Health Care
  • Exchange
  • WIMI Nasdaq
  • ARMP Nasdaq
  • Market Cap
  • WIMI 92.2M
  • ARMP 80.0M
  • IPO Year
  • WIMI 2020
  • ARMP N/A
  • Fundamental
  • Price
  • WIMI $0.88
  • ARMP $2.08
  • Analyst Decision
  • WIMI
  • ARMP Strong Buy
  • Analyst Count
  • WIMI 0
  • ARMP 1
  • Target Price
  • WIMI N/A
  • ARMP $7.00
  • AVG Volume (30 Days)
  • WIMI 5.2M
  • ARMP 7.1K
  • Earning Date
  • WIMI 01-01-0001
  • ARMP 03-20-2025
  • Dividend Yield
  • WIMI N/A
  • ARMP N/A
  • EPS Growth
  • WIMI N/A
  • ARMP N/A
  • EPS
  • WIMI N/A
  • ARMP N/A
  • Revenue
  • WIMI $84,137,968.00
  • ARMP $5,467,000.00
  • Revenue This Year
  • WIMI N/A
  • ARMP $23.87
  • Revenue Next Year
  • WIMI N/A
  • ARMP N/A
  • P/E Ratio
  • WIMI N/A
  • ARMP N/A
  • Revenue Growth
  • WIMI 19.25
  • ARMP 34.92
  • 52 Week Low
  • WIMI $0.63
  • ARMP $1.80
  • 52 Week High
  • WIMI $2.92
  • ARMP $4.48
  • Technical
  • Relative Strength Index (RSI)
  • WIMI 41.83
  • ARMP 51.22
  • Support Level
  • WIMI $0.87
  • ARMP $1.97
  • Resistance Level
  • WIMI $0.92
  • ARMP $2.12
  • Average True Range (ATR)
  • WIMI 0.11
  • ARMP 0.11
  • MACD
  • WIMI -0.02
  • ARMP -0.00
  • Stochastic Oscillator
  • WIMI 7.89
  • ARMP 27.50

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings primarily consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: